Updates on the Systemic Treatment of Advanced Non-melanoma Skin Cancer
Keiji Tanese(Toho University), Takeru Funakoshi(Keio University), Yoshio Nakamura(Keio University), Ikuko Hirai(Keio University)
Cited by 45
Related Papers
Nivolumab for advanced melanoma: pretreatment prognostic factors and early outcome markers during therapy
|Oncotarget|2016|160
Diagnosis and Management of Basal Cell Carcinoma
|Current Treatment Options in Oncology|2019|153
G-Protein-Coupled Receptor GPR49 is Up-regulated in Basal Cell Carcinoma and Promotes Cell Proliferation and Tumor Formation
|American Journal Of Pathology|2008|141
Anti-PD1 checkpoint inhibitor therapy in acral melanoma: a multicenter study of 193 Japanese patients
|Annals of Oncology|2020|140
Cell Surface CD74–MIF Interactions Drive Melanoma Survival in Response to Interferon-γ
|Journal of Investigative Dermatology|2015|95